Clinical Study on Pingwei Capsules for 45 Cases of Chronic Atrophic Gastritis with Precancerous Lesions of Gastric Cancer

YANG Shaojun; WANG Longde; ZHANG Jing; WANG Qi

doi:10.13288/j.11-2166/r.2014.20.010

您当前的位置：

首页 >

文章列表页 >

Clinical Study on Pingwei Capsules for 45 Cases of Chronic Atrophic Gastritis with Precancerous Lesions of Gastric Cancer

更新时间：2021-11-17

- Clinical Study on Pingwei Capsules for 45 Cases of Chronic Atrophic Gastritis with Precancerous Lesions of Gastric Cancer
- Journal of Traditional Chinese Medicine Vol. 55, Issue 20, Pages: 1745-1749(2014)
- 作者机构：
  
  1. 甘肃中医学院附属医院
  2. 甘肃中医学院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2014.20.010
  CLC： R259
- Published：2014
- 稿件说明：
移动端阅览
[1]杨少军,汪龙德,张晶,王琦.平胃胶囊治疗慢性萎缩性胃炎癌前病变45例临床研究[J].中医杂志,2014,55(20):1745-1749.

YANG Shaojun, WANG Longde, ZHANG Jing, et al. Clinical Study on Pingwei Capsules for 45 Cases of Chronic Atrophic Gastritis with Precancerous Lesions of Gastric Cancer[J]. Journal of Traditional Chinese Medicine2014, 55(20): 1745-1749.
[1]杨少军,汪龙德,张晶,王琦.平胃胶囊治疗慢性萎缩性胃炎癌前病变45例临床研究[J].中医杂志,2014,55(20):1745-1749. DOI： 10.13288/j.11-2166/r.2014.20.010.

YANG Shaojun, WANG Longde, ZHANG Jing, et al. Clinical Study on Pingwei Capsules for 45 Cases of Chronic Atrophic Gastritis with Precancerous Lesions of Gastric Cancer[J]. Journal of Traditional Chinese Medicine2014, 55(20): 1745-1749. DOI： 10.13288/j.11-2166/r.2014.20.010.

摘要

目的观察平胃胶囊治疗慢性萎缩性胃炎癌前病变（PLGC）临床疗效及可能作用机理。方法将80例PLGC患者分为治疗组45例和对照组35例。治疗组给予平胃胶囊口服

每次4粒

每日3次。对照组给予维酶素片

每次4片

每日3次。两组均治疗6个月。观察治疗前后两组患者临床症状、临床疗效、胃镜及胃黏膜组织中表皮生长因子（EGF）、肠道特异性转录因子（CDX2）表达的变化。结果治疗组临床疗效总有效率为91.1%

对照组为77.1%

治疗组明显优于对照组（P<0.05）。两组患者治疗后症状积分均明显下降（P<0.05）;治疗组治疗后症状积分明显低于对照组（P<0.05）。治疗组病理改善率为51.1%

对照组为31.4%

治疗组病理改善率明显优于对照组（P<0.05）。治疗后治疗组糜烂、黏膜白相、颗粒增生、血管透见、胆汁反流改善率明显优于对照组（P<0.05）。两组患者治疗后胃黏膜上皮细胞EGF阳性表达率较治疗前均明显降低（P<0.05）;两组患者治疗后EGF阳性表达率比较

差异无统计学意义（P>0.05）。治疗组治疗后Ⅰ型肠化、Ⅱ型肠化、异型增生CDX2阳性表达率明显下降（P<0.01）。对照组治疗后Ⅰ型肠化、Ⅱ型肠化CDX2阳性表达率均明显下降（P<0.01）。治疗后治疗组Ⅰ型肠化、Ⅱ型肠化PLGC胃黏膜组织中CDX2阳性表达率明显低于对照组（P<0.05）。结论平胃胶囊能有效改善PLGC患者的临床症状和病理改变

改善胃黏膜血液循环

使黏膜再生加强并得到修复

同时抑制EGF和CDX2的表达

使癌前病变PLGC得以有效逆转。

Abstract

Objective To observe the efficacy and mechanism of Pingwei Capsules for chronic atrophic gastritis with precancerous lesions of gastric cancer（ PLGC）. Methods Totally 100 cases of PLGC were randomized into the treatment group and control group

with 50 in each. There were 5 cases excluded and 45 cases remained in the treatment group. There were 15 cases excluded and 35 cases remained in the control group. The treatment group was given Pingwei Capsules（ 4 caps once and three times daily）. The control group was given Vitacoenzyme Tablets（ 4tablets once and three times daily）. The treatment lasted for 6 months. The symptoms

gastroscope results and the expressions of vascular endothelial growth factor（ VEGF） and CDX2 were observed before and after treatment in both groups. Results The total effective rate of the treatment group and control group was 91. 1% and 77. 1% respectively

with a significant difference between groups（ P < 0. 05）. After treatment

the symptom scores were significantly decreased in both groups（ P < 0. 05）

especially in the treatment group（ P < 0. 05）. The pathological improvement rate in the treatment group and control group was 51. 1% and 31. 4% respectively

with a significant difference between groups（ P < 0. 05）. After treatment

the improvement rates of erosion

mucosal Shiraai

particle hyperplasia

vascular permeability and bile reflux in the treatment group were superior to those in the control group（ P < 0. 05）.The expression of VEGF was significantly decreased after treatment in both groups（ P < 0. 05）. There was no significant difference between groups in the expression rate of VEGF（ P > 0. 05）. After treatment

the positive expression rate of CDX2 in type I intestinal metaplasia（ IM）

type Ⅱ IM and dysplasia was significantly decreased in the treatment group（ P < 0. 01）. After treatment

the positive expression rate of CDX2 in type I IM and type Ⅱ IM was significantly decreased in the control group（ P < 0. 01）. After treatment

the positive expression rate of CDX2 in type I IM and type Ⅱ IM in the treatment group was significantly lower than that in the control group（ P < 0. 05）.Conclusion Pingwei Capsules can effectively relieve the symptoms and pathological changes of PLGC patients

promote the expression of VEGF

improve gastric blood circulation

strengthen and repair the mucosal regeneration

inhibit the expression of CDX2 and reverse precancerous lesions.

关键词

Keywords

references

查看原文

Views

386

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Observation on Xiaopi Yuwei Decoction with Weifuchun Tablets in the Treatment of 64 cases of Chronic Atrophic Gastritis with Intestinal Metaplasia or Dysplasia

A Clinical Observation on Turbidity-Transforming Toxin-Resolving Formula Combined with Acupuncture for 40 Cases of Chronic Atrophic Gastritis

Meta-analysis of Therapeutic Effect of Removing Turbidites and Detoxication Method in Treating Chronic Atrophic Gastritis

Efficacy and Economic Evaluation of Weishi Qingjin Formula （苇石清金方）in the Treatment of Adult Community-Acquired Pneumonia with Phlegm-Heat Obstructing the Lung Syndrome：A Multicenter Retrospective Real-World Cohort Study

The Philosophy and Practical Pathway of "Dao （道）-Shen （神）-Formula" in Traditional Chinese Medicine

Related Author

ZHENG Fengmin

ZHENG Lele

ZHENG Zhongjian

PEI Lin2

ZHANG Yuejin3

ZHANG Weiran3

MI Huiru3

HE Hua2

Related Institution

Rui’an Hospital of Traditional Chinese Medicine

Hebei Medical University

TCM Hospital of Hebei Province

Central Hospital of Shijiazhuang City

Hebei Hospital of Chinese Medicine

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰